A review on newly approved PARP inhibitors: Talazoparib and Olaparib

A review on newly approved PARP inhibitors: Talazoparib and Olaparib

This project report is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.

Dades bibliogràfiques
Autor principal:	Karim, Azrin
Altres autors:	Islam, Farzana
Format:	Project report
Idioma:	English
Publicat:	Brac University 2024
Matèries:	PARP inhibitors Olaparib Talazoparib DNA damage repair DDR signaling pathway Homologous recombination repair Prostate cancer Ovarian cancer Metastatic breast cancer BRCA mutations Cancer > Treatment > Genetic aspects. DNA repair. NAD-ADP-ribosyltransferase > Inhibitors > Therapeutic use. Antineoplastic agents.
Accés en línia:	http://hdl.handle.net/10361/24372

Ítems similars

A review on potential of PARP inhibitors in the treatment of prostate cancer
per: Islam, Saidul
Publicat: (2022)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
per: Ahmed, Nafisa
Publicat: (2023)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
per: Meem, Manila
Publicat: (2023)

Mutation in DNA polymerase γ: mitochondrial disorders
per: Hossain, Sadman Sanjid
Publicat: (2023)

RIPK pathway, as a potential target, for cancer treatment - a review
per: Jahan, Nusrat
Publicat: (2024)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
per: Alam, Tahera
Publicat: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
per: Flora, Sanzida Alam
Publicat: (2024)

Immunotherapy in the Management of Lung Cancer
per: Tasnim, Humayra
Publicat: (2022)

Statistics and informatics in molecular cancer research

Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population
per: Parvin, Salma, et al.
Publicat: (2016)

Association of MTHFR rs1801133, PEMT rs4244593, CHKA rs7928739, VNTRs IL-1RN intron 2 and NOS3 intron 4 polymorphisms with unexplained intrauterine fetal death in Bangladeshi population
per: Mahasin, Deera, et al.
Publicat: (2024)

Repairing & maintaining yard equipment & power tools /
per: Schultz, Mort J.
Publicat: (1994)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
per: Mirza, Maisa Tasnim
Publicat: (2023)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
per: Ratu, Tabassum
Publicat: (2024)

Cancer risk factors: a critical review
per: Tabassum, Tahsina
Publicat: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
per: Nawar, Anika
Publicat: (2019)

Repurposing Albendazole and Mebendazole, an antiparasitic drug in treating colorectal cancer- a review
per: Mondal, Shawon
Publicat: (2023)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
per: Khan, Muidul Hasan
Publicat: (2024)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
per: Abir, Shifaty Nur
Publicat: (2024)

Targeting BRAFV600E in the treatment of CRC
per: Roja, Mashwiyat Samrin
Publicat: (2024)

Role of statins as antagonists of SPARC in gastric cancer
per: Shahmat, Rad
Publicat: (2019)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
per: Pial, Sazia Afrin
Publicat: (2018)

A review on the role of histone deacetylase SIRT6 in high-grade serous ovarian Cancer
per: Rahman, Tazin
Publicat: (2022)

Epigenetic therapy in cancer
per: Abid, Md. Shadman Ridwan
Publicat: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
per: Khondokar, Faiza
Publicat: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
per: Rahman, Sanjida
Publicat: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
per: Emon, Kamrul Hasan
Publicat: (2022)

Biosimilar in lymphoma treatment
per: Tanisha, Mehrin Haque
Publicat: (2021)

Molecules associated with the development of lung cancer
per: Rahman, Adree, et al.
Publicat: (2023)

Current perspectives on cancer prevention strategies: implications for Bangladesh
per: Afrin, Sajia
Publicat: (2017)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
per: Hossain, Safa Binte
Publicat: (2019)

Potential of nanoparticles as a topical drug delivery system for skin cancer: a review
per: Islam, Karima
Publicat: (2022)

ক্যান্সার : মৃত্যু অবধারিত নয় /
per: করীম, আবুল বাশার মোহাম্মদ ফজলুল

Point-of care diagnostic devices in cancer detection
per: Yasmin, Rizwana
Publicat: (2022)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
per: Sorno, Rubina Haque
Publicat: (2024)

Radar for technicians : installation, maintenance, and repair /
per: Gould, Frederick L.
Publicat: (1995)

Breast cancer awareness seminars
per: Anwer Khan Modern Medical College
Publicat: (2016)

Protein biomarkers for Lung Cancer: a bioinformatic approach
per: Jeba, Joynob
Publicat: (2017)

Current scenario of Cancer in Dhaka City, Bangladesh
per: Natth, Bratakatha
Publicat: (2016)

Molecular biology of cancer : mechanisms, targets, and therapeutics /
per: Pecorino, Lauren
Publicat: (2012)